- Apr 3, 2022
- 1 min read

Report: In big shift, medtech executives grow fonder of U.S. regulatory process

By: Joel Berg

Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.

Recent Posts

See All

Meet Jay Goss, General Partner at Wavemaker THREE-SIXTY HEALTH

By: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups than ever, there's

MATTERWORKS ANNOUNCES UPDATES TO ITS BOARD OF DIRECTORS

Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updat

Luna Teams Up with UCI Health to Expand Access to Care with In-Home Outpatient Physical Therapy

Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing in-home physical therapy across Orange County, California. With a f